Enhanced plasma and brain concentrations and medulloblastoma cytotoxicity of asciminib and nilotinib by P-glycoprotein inhibition with tariquidar
Anticancer Drugs. 2025 Apr 18. doi: 10.1097/CAD.0000000000001728. Online ahead of print. ABSTRACT ABL1 and ABL2 are putative drivers of medulloblastoma leptomeningeal dissemination. ABL1/ABL2 inhibitors, nilotinib …